Fibrinolysin (Fibrinolysin)

Fibrinolysin, also known as fibrinolysin enzyme, is a protein enzyme that is capable of breaking down fibrin, the main component of blood clots. Fibrinolysin may also have an anti-inflammatory effect and speed up the healing process of wounds.

Fibrinolysin was discovered in 1933 by scientists from Sweden. Since then, it has found wide application in medicine, especially in the treatment of thrombosis and other diseases associated with impaired blood flow.

The action of fibrinolysin is based on its ability to activate plasminogen, which in turn is converted to plasmin. Plasmin, in turn, is the main enzyme responsible for the destruction of fibrin.

Fibrinolysin can be used to treat thrombosis, myocardial infarction, pulmonary embolism, thrombophlebitis, venous thromboembolism and other diseases associated with impaired blood flow. It can also be used to speed up wound healing and resolve bruises.

Like any medicine, fibrinolysin may have side effects such as allergic reactions, bleeding and others. Therefore, the use of fibrinolysin should be carried out only under the supervision of a physician and as prescribed.

In conclusion, fibrinolysin is an important enzyme that has wide application in medicine. It is able to speed up the healing process of wounds and treat many diseases associated with impaired blood flow. However, like any medical drug, its use should only be carried out under the supervision of a physician.

Fibrinolysin, fibryolysis, fibrinogen lysis - a system of enzymatic breakdown of fibrin under the action of the enzyme fibrinolase contained in the blood and tissues of the body; plasmin.

**Description** Fibrinolysis is the process of breakdown of fibrin filaments in the blood, which occurs through the process of plasmin activation (fibrinolysis). Plasmin is the main enzyme that